Abdominal Aortic Aneurysms Clinical Trial
Official title:
The Use of Carbon Dioxide as a Contrast Media for Performing Endovascular Procedures
Prospective randomized comparison between endovascular procedures performed with iodinated contrast or carbon dioxide as intraarterial contrast.
120 patients will undergo endovascular procedures: 40 for the treatment of lower limb ischemia caused by aortoiliac stenosis classified according to the consensus for the management of peripheral arterial disease (TASC) A or B with an indication for angioplasty as the inclusion criteria; 40 for the treatment of lower limb ischemia due to stenosis femoropopliteal TASC A or B with an indication of angioplasty as the inclusion criteria and 40 for the treatment of abdominal aortic aneurysm (AAA) with indication for endovascular repair. Of these procedures, half chosen randomly by computerized simple random, will be submitted to the endovascular procedure in question using only iodinated contrast and the other half will be submitted to the endovascular procedure using carbon dioxide (CO2). There will be no CO2 injection in the aortic arch or cerebral territory. The patient previously evaluated at the Hospital Municipal Dr. Moses Deutsch will be referred to the operating room of the Albert Einstein Hospital where it will be performed under general anesthesia with intubation or blockage associated with sedation, and the same in the supine position (DDH).The femoral artery will be punctured with Seldinger technique unilaterally or bilaterally, according to the indication for the procedure. By using the guide wire will be one or two sheaths inserted in a retrograde manner. Through the introducer, is manually injected retrogradely 50 ml of CO 2, in obtaining images of the apparatus module CO2 Philips mode subtraction angiography. In angioplasty for obstructive disease, with the module roadmap will be held the passage of the guidewire through the stenotic region or occlusion, and dilatation balloon angioplasty specific. After angioplasty, there will be a new injection of contrast for the evaluation of partial results. As appropriate, will be held stent placement, in which case there will be a last angiography with 50 ml of CO2. In endovascular repair of abdominal aortic aneurysms, there will be a first injection of CO2 for the study of the neck of the aneurysm and stent implantation. After the release of the entire stent, a new angiography is performed by injection of CO2 for the control of surgical outcome. In all procedures will be performed to measure pressure through the femoral sheath prior to angioplasty, after angioplasty and stent after the placement. During the use of CO2 as contrast medium, with questions at the trial of such factors as the extent of injury, indication of repair, endoleak, leak, rupture or thrombosis by arteriography will be performed by manual injection of iodinated contrast.Of course this amount of contrast is measured. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02888613 -
Mini-laparotomy Versus Mini Lumbotomy
|
N/A | |
Recruiting |
NCT00662480 -
Randomized Preventive Vascular Screening Trial of 65-74 Year Old Men in the Central Region of Denmark
|
Phase 4 | |
Terminated |
NCT00372138 -
Prevention of Endoleaks Using Autologous Platelet Gel on Unruptured Abdominal Aortic Aneurysms
|
N/A | |
Completed |
NCT00989729 -
Preoperative Methylprednisolone in Endovascular Aortic Repair
|
N/A | |
Active, not recruiting |
NCT02345005 -
Iliac Branch Excluder ReGistry (IceBERG)
|
||
Completed |
NCT01390740 -
Observatory of Screening Aneurysms of the Abdominal Aorta During Echocardiography. National Epidemiological Survey
|
||
Completed |
NCT00833924 -
Zenith(R) Low Profile AAA Endovascular Graft Clinical Study
|
N/A | |
Terminated |
NCT00610090 -
Safety Study for the Treatment of Abdominal Aortic Aneurysms
|
Phase 2 | |
Completed |
NCT02477111 -
European (EU) Post Approval Study of the INCRAFT® AAA Stent Graft System in Subjects With Abdominal Aortic Aneurysms
|
||
Recruiting |
NCT01538056 -
Physician Modified Endovascular Grafts
|
N/A | |
Completed |
NCT01106391 -
A Multicenter, Open Label, Prospective, Non-Randomized Study Of INCRAFT™ In Subjects With AAA (INNOVATION)
|
N/A | |
Terminated |
NCT00444821 -
The (PIVOTAL) Study
|
N/A | |
Completed |
NCT01599533 -
Screening for Thoracic Aortic Aneurysm Among a Cohort of Patients With a Degenerative Abdominal Aortic Aneurysm
|
N/A | |
Completed |
NCT01328197 -
Treovance Stent-Graft With Navitel Delivery System for Patients With Infrarenal Abdominal Aortic Aneurysms
|
Phase 1 | |
Completed |
NCT00705718 -
Endurant Bifurcated and Aorto-Uni-Iliac (AUI) Stent Graft System
|
N/A | |
Completed |
NCT02125890 -
Effect of Tranexamic Acid in Ruptured Abdominal Aortic Aneurysms
|
Phase 3 | |
Completed |
NCT00875563 -
Zenith(R) Fenestrated Abdominal Aortic Aneurysm (AAA) Endovascular Graft Clinical Study
|
N/A | |
Completed |
NCT02048514 -
The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms
|
N/A | |
Terminated |
NCT00546013 -
Abdominal Aortic Aneurysms and Pseudoexfoliation Syndrome
|
N/A | |
Recruiting |
NCT05004051 -
ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA
|